a public good project by the
Synthesis
Company
of California

© 2026

Jashvant D. Unadkat | doi.page

0 works0 citations0 h-index

Jashvant D. Unadkat

Washington State University Spokane(US)University of Washington(US)University of Chicago(US)

Publications by Year

Research Areas

Drug Transport and Resistance Mechanisms, Pharmacological Effects and Toxicity Studies, Pharmacogenetics and Drug Metabolism, HIV/AIDS drug development and treatment, Pregnancy and Medication Impact

Most-Cited Works

→ Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update(2014)638 cited
→ Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography(2005)268 cited
→ Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice(2009)263 cited
→ Protein Abundance of Clinically Relevant Multidrug Transporters along the Entire Length of the Human Intestine(2014)252 cited
→ Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study(2008)249 cited
→ Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance(2018)226 cited

Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities.(1998)

→ HIV Protease Inhibitors Are Inhibitors but Not Substrates of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)(2004)216 cited

→ Interindividual Variability in Hepatic Organic Anion-Transporting Polypeptides and P-Glycoprotein (ABCB1) Protein Expression: Quantification by Liquid Chromatography Tandem Mass Spectroscopy and Influence of Genotype, Age, and Sex(2013)193 cited

→ Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease(2014)188 cited